IP Library › Assignment 023353/0549
Patent Assignment
Reel/Frame 023353/0549

Corrective Assignment to Correct the Assignee Previously Recorded on Reel 022511 Frame 0111. Assignor(S) Hereby Confirms the Assignee to Be Roche Palo Alto Llc.

Recorded: 2009-10-09 Pages: 6
Assignor
SMITH, DAVID BERNARD
Executed: 2009-04-01
Assignee
ROCHE PALO ALTO LLC
3431 HILLVIEW AVENUE, PALO ALTO, CALIFORNIA, 94304
Covered Property (1)
Nucleoside Prodrugs and Uses Thereof
Patent: 8,063,025 →
Application: 12/313,992 →
Publication: US 2009/0209481
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 6, 2009
From: SMITH, DAVID BERNARD
To: METABASIS THERAPEUTICS, INC.
Reel/Frame 022511/0111 →
Assignment of Assignor's Interest Jun 15, 2009
From: HECKER, SCOTT J.; REDDY, K. RAJA; BOOKSER, BRETT C.; SUN, ZHILI
To: METABASIS THERAPEUTICS, INC.
Reel/Frame 022825/0509 →
Assignment of Assignor's Interest Feb 24, 2011
From: ROCHE PALO ALTO LLC
To: METABASIS THERAPEUTICS, INC.
Reel/Frame 025860/0636 →
Security Interest Oct 18, 2023
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; PFENEX INC.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065271/0025 →